Commissioner: Hamilton County cancer rates above average; county expands screenings and weighs insulin-pricing litigation At the Oct. 16 meeting Commissioner Alicia Reese summarized the second annual State of Cancer caucus and 5|13 health expo, highlighting higher county cancer rates and expanded free screenings; she said she supports meeting with the prosecutor to explore joining insulin-pricing litigation.

Hamilton County's cancer rates are alarmingly high, prompting urgent discussions on expanding screenings and tackling insulin prices for residents in need.

Click to read more!

#HamiltonCounty #OH #CitizenPortal #HealthScreenings #InsulinAccess #CancerPrevention

California To Start Selling Its Own Brand Of Affordable, $11 Insulin - IndiaWest News California To Start Selling Its Own Brand Of Affordable, $11 Insulin.

California To Start Selling Its Own Brand Of Affordable, $11 Insulin

Full Story: indiawest.com/california-t...

#CalRxInsulin #AffordableInsulin #GavinNewsom #BigPharmaChallenge #DiabetesCare #HealthEquity #PrescriptionReform #StateBrandedDrugs #InsulinAccess

Oregon Prescription Drug Affordability Board June, 18, 2025 Meeting Highlights presented by OCAP

Which Drugs Made the List? 16 prescription drugs and 7 insulin products selected for affordability review 4 orphan drugs (e.g., Humira, Botox) removed due to current statute Selection focused on cost (net payer) and patient volume

What's Powering the Decisions? Data from 11 commercial insurers (net cost) APAC data (gross cost incl. Medicare/Medicaid) New PDAB dashboard features: Drug lookup NDC info Plan designs

Looking Ahead Next PDAB Meeting: July 16, 2025 @ 9 AM Tune in for the start of affordability reviews! Insulin review scheduled for later in 2025 Public hearing on PBM rulemaking: June 23 Board member recruitment extended to July 7

At last week's meeting, the Oregon Prescription Drug Affordability Board (#PDAB) reviewed data, approved a 16-drug review list, and discussed #insulin pricing. Learn more in the slides →

Next meeting: July 16, 2025 at 9 AM.

#OregonPDAB #DrugAffordability #HealthPolicy #InsulinAccess #OCAP

AB555 would require private insurers to cap insulin at $35 for a 30-day supply — with no extra deductibles, copays, or surprise fees.

Healthcare should be affordable! 🙌

#AB555 #InsulinPriceCap #DiabetesCare #InsulinAccess #HealthCareForAll #NevadaStrong #DiabetesSupport #NVCapital #NVLeg #ForYou

1/n "None of the patients with #type1diabetes I have treated have survived past the age of 25," says Dr Royson Dsouza, working in Gudalur, South India. While #insulin and #insulinaccess remains a deeply politicised issue in the western world, access to insulin in the developing world is limited by